Joint Statement on Impact of Shutdown on Therapy Review
The following statement is posted in response to published reports concerning the impact of the government shutdown on review by the Food and Drug Administration (FDA) of therapies for food allergy:
We are hopeful that the government shutdown will end as soon as possible so that the FDA can get back to work reviewing potential food allergy treatments. It is imperative that any potential treatments are processed through the system quickly, as patients' lives are at stake.
Delays of any kind prolong the long wait for a potentially life-saving therapy for peanut allergy. We hope that our leaders can find a way to reach an agreement and let the FDA continue their work.
--Allergy & Asthma Network, Asthma and Allergy Foundation of America, Center for Science in the Public Interest and Food Allergy Research & Education
Media Contact:
About FARE
FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—advocacy, research, and education—united by the through line of health equity. FARE’s initiatives accelerate the future of food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. For more information, visit FoodAllergy.org.